Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 46 (6), 888-894
- https://doi.org/10.1016/j.neuropharm.2003.11.018
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to PaclitaxelGynecologic Oncology, 2002
- Hypersensitivity Reactions in Ovarian Cancer Patients Receiving PaclitaxelJournal of Chemotherapy, 1999
- Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactionsAnnals of Oncology, 1997
- Peripheral effects of three novel non-peptide tachykinin NK1 receptor antagonists in the anaesthetized ratEuropean Journal of Pharmacology, 1996
- Paclitaxel Premedication RegimensJNCI Journal of the National Cancer Institute, 1996
- A Preliminary Risk-Benefit Assessment of PaclitaxelDrug Safety, 1995
- Sodium cromoglycate: evidence of tachykinin antagonist activity in the human skinJournal of Applied Physiology, 1993
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992
- Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptidesNeuroscience, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976